CDN Connection Issue

It appears that your current network does not allow connection to the CDN (Content Delivery Network) required for this service to function properly.

To resolve this issue, please try the following actions :

• Contact your network administrator : Inform them of this restriction so they can adjust the network settings accordingly.

• Use another network : Try connecting from a different network, such as another Wi-Fi network or a mobile connection.

We apologize for the inconvenience and thank you for your understanding.

ERS Vision Live

Released on 28.10.2025

Pulmonary toxicity

Overview

Taking place on 11 November, this ERS Vision Live panel discussion covered key areas, including:

when to suspect drug-induced lung toxicity;
radiological features of drug-induced lung toxicity;
drug-induced lung toxicity during lung cancer therapies.

Speakers

Prof. Vincent Cottin (Co-chair)

Vincent is Professor of Respiratory Medicine and Coordinator of the National Reference Center for Rare Pulmonary Diseases at the Louis Pradel Hospital and the University of Lyon, France.
His research interests include rare 'orphan' pulmonary diseases including all interstitial lung diseases and rare pulmonary diseases.
Vincent has served as elected Head of the ERS Clinical Assembly from 2009 to 2012.
He coordinates the network of rare diseases centers in France.
He has been Chief Editor of the European Respiratory Review, and Section Editor of the European Respiratory Journal where he is currently an associate editor and has been Associate Editor of Respiration.

Prof. Paolo Spagnolo (Co-chair)

Paolo is a full professor of respiratory medicine at the University of Padua, Italy; and Director of the Respiratory Unit at the University Hospital of Padua.
His main research interests include interstitial lung disease and sarcoidosis with emphasis on genetic predisposition, prediction of disease behaviour and clinical trials of novel therapies.
Paolo is the author or co-author of over 200 journal articles, review articles and editorials.
He is Editor-in-Chief of Sarcoidosis, Vasculitis and Diffuse Lung Diseases.

Dr Sara Piciucchi

Sara is a doctor at the Radiology Department of G.B. Morgagni-Pierantoni Hospital in Forlì, Italy, and is affiliated with the University of Bologna, Italy.
She completed her radiology residency at Campus Bio Medico of Rome University, Italy, as well as a master's in paediatric cardiology.
Sara has completed several fellowships and observerships in chest and cardiovascular imaging at leading institutions, including the Medical College of Wisconsin, Mayo Clinic Arizona, United Sates, and Thoraxklinik Heidelberg, Germany.
In addition to her clinical and academic roles, she serves as Secretary of the ERS Assembly 14 Imaging Group, and is an associate editor of Sarcoidosis, Vasculitis and Diffuse Lung Diseases.

Dr Nazia Chaudhuri

Nazia is a respiratory physician with a specialist interest in ILD.
She is a senior clinical lecturer at Ulster University, Northern Ireland, United Kingdom, and Lead of the Northern Ireland ILD Network.
She is Chair of the British Thoracic Society (BTS) ILD Registry Working group and was Chair of the BTS Interstitial and Rare Lung Disease Specialist Advisory Group from November 2020 to 2023.
She is also a member of the European Respiratory Society (ERS) ILD Long Range Planning Committee, an ERS ILD mentor, and has recently been appointed as Secretary of the ERS Assembly 12 (ILD) Idiopathic Interstitial Pneumonia Group.

Prof. Philippe Bonniaud

Philippe is a professor of respiratory medicine and heads the "Institut Universitaire du Poumon" of Dijon University Hospital, France. He also coordinates the Constitutive Reference Center for Rare Pulmonary Diseases, France.
He conducts research on ILD, with a specific focus on drug-induced lung diseases.
From 2015-2018, he was Chair of ERS Assembly 3 (Basic and Translational Sciences) Molecular Pathology and Functional Genomics Group.
He has been a Fellow of the ERS since 2019.

Recent episodes

Watch previous episodes

Antimicrobial resistance

Respiratory health around the globe - common problems and shared solutions

Type 2-low asthma - where do we go now?

Adaptive servoventilation for central sleep apnoea

Sarcoidosis - bringing innovation into clinical practice

Cough: new therapies

AI and lung cancer

Review of the world symposium on PH

Load more